Диссертация (1174243), страница 20
Текст из файла (страница 20)
– Р.1094—1100. http://dx.doi.org/10.1177/193229680800200618.149.Mortality in diabetic patients with cardiovascular autonomic neuropathy /W. Rathmann, D. Ziegler, M. Jahnke et al. // Diabet. Med. - 1993. - Vol.10. – Р.820–824.150.Nalysnyk, L. Glycaemic variability and complications in patients withdiabetes mellitus: evidence from a systematic review of the literature / L. Nalysnyk,М. Hernandez-Medina, G. Krishnarajah // Diabetes.
Obes. Metab. - 2010. - Vol.12,4. – Р.288–298.151.Nathan, D. M. The diabetes control and complications trial/epidemiology ofdiabetes interventions and complications study at 30 years: overview/ D. M. Nathan,DCCT EDIC Research Group. //Diabetes Care. - 2014. - Vol.37, 1. –Р.9-16. doi:10.2337/dc13-2112152.Neurocognitive functioning in children with type-1 diabetes with and withoutepisodes of severe hypoglycaemia / R. Hannonen, S. Tupola, T. Ahonen, R.
Riikonen// Dev. Med. Child. Neurol. – 2003. - Vol.45. – Р.262–268.128153.Neuropsychological profiles of children with type 1 diabetes 6 years afterdisease onset / Е. А. Northam, P. J. Anderson, R. Jacobs et al. // Diabetes Care. 2001. - Vol. 24. - Р.1541–1546.154.O‘Brian, I. A. The influence of autonomic neuropathy on mortality in insulin-dependent diabetes / I. A. O‘Brian, J. P. McFadden, R. J. Corrall // Q.
J. Med. –1991. - Vol.79. – Р.495–502.155.Osipoff, J. N. Prime-time hypoglycemia: factitious hypoglycemia duringinsulin-pump therapy/J. N. Osipoff, N. Sattar, T. A Wilson //Pediatrics. - 2010. -Vol.125. - P.е1246-е1248.156.Patton, S. R. Evaluation of the average daily risk range as a measure ofglycemic variability in youths with type 1 diabetes / S. R. Patton, S. A. DeLurgio,M. A. Clements// Diabetes Technology & Therapeutics.
– 2015. - Vol.17, 11. –Р.795-800. DOI: 10.1089/dia.2015.0061157.Patton, S. R. Mealtime interactions relate to dietary adherence and glycemiccontrol in young children with type 1 diabetes / S. R. Patton, L. M. Dolan, S. W.Powers //Diabetes Care. - 2006. - Vol.29. –Р.1002–1006. [PubMed: 16644628]158.Predictors of acute complications in children with type 1 diabetes. / A.Rewers, H.
P. Chase, T. Mackenzie et al. //JAMA. – 2002. - Vol. 287. – Р. 2511–2518.159.Prevalence of structural central nervous system abnormalities in early-onsettype 1 diabetes mellitus / M. S. Ho, N. J. Weller, F. J. Ives et al. //J. Pediatr. – 2008. Vol.153. - Р.385–390.160.Prevalence of QT interval dispersion in type 1 diabetes and its relation withcardiac ischaemia: the EURODIAB IDDM Complications Study Group / M. Veglio,S. Giunti, L.
K. Stevens et al. // Diabetes Care. - 2002. - Vol.25. –Р. 702-707.161.Prolonged nocturnal hypoglycemia is common during 12 months ofcontinuous glucose monitoring in children and adults with type 1 diabetes / Juvenilediabetes research foundation continuous glucose monitoring study group//DiabetesCare. – 2010. - Vol.33. – Р.1004–1008.129162.Prolonged use of continuous glucose monitors in children with type 1 diabeteson continuous subcutaneous insulin infusion or intensive multiple-daily injectiontherapy / S. Weinzimer, D. Xing , M. Tansey et al.// Pediatr.
Diabetes. - 2009.Vol.10. – Р.91-96.163.Relating mean blood glucose and glucose variability to the risk of multipleepisodes of hypoglycaemia in type 1 diabetes / E. S. Kilpatrick, A. S. Rigby, K.Goode, S. L. Atkin // Diabetologia. - 2007. - Vol. 50. – Р.2553–2561.164.Role of counterregulatory hormones for glucose metabolism in children andadolescents with type 1 diabetes/ Akiko Nishimura, Kisho Kobayashi, HideakiYagasaki et al. //Clin.
Pediatr. Endocrinol. – 2011. - Vol.20, 4. –Р. 73-80.165.Severe hypoglycemia and diabetic ketoacidosis among youth with type 1diabetes in the T1D Exchange clinic registry / E. Cengiz, D. Xing, J. C. Wong et al.//Pediatr. Diabetes. - 2013. - Vol.14. – Р.447–454.166.Siegelaar, S. E. Glucose variability; does it matter /S. E. Siegelaar, F.Holleman, J. B. L. Hoekstra, J.H. De Vries //Endocrine Reviews.
– 2010. - Vol.31, 2.– Р.171-182.167.Should all patients with type 1 diabetes mellitus and microalbuminuria receiveangiotensin А converting enzyme inhibitors? A meta-analysis of individual patientdata / ACE Inhibitors in Diabetic Nephropathy Trialist Group // Annals of InternalMedicine. - 2001. - Vol.134,5. – Р.
370–379.168.Simple tests to screen for diabetic peripheral neuropathy / Z. Yang, Y. Zhang,R. Chen et al. // Cochrane Database of Systematic Reviews. - 2014. - Issue 2. - Art.No.: CD010975. DOI: 10.1002/14651858.CD010975.169.Soha M. Abd El Dayem. Effect of glycemic control on the progress of leftventricular hypertrophy and diastolic dysfunction in children with type I diabetesmellitus /Soha M. Abd El Dayem, Ahmed A.
Battah // Anadolu. Kardiyol. Derg. 2012. – Vol. 12. – Р.498-507.170.Subclinical vascular endothelial dysfunctions and myocardial changes withtype 1 diabetes mellitus in children and adolescents / Azza Eltayeb, Douaa Sayed,130Faisal-Alkhateeb Ahmad Amany M. Osama // Pediatric cardiology. - 2014. - Vol.35, 6.
– Р.965-974. doi: 10.1007/s00246-014-0883-9.171.Structural equation modeling of symptoms, awareness and fear ofhypoglycemia, and personality in patients with insulin-treated diabetes/ D. A.Hepburn, I. J. Deary, K. M. MacLeod et al. // Diabetes Care. – 1994. – Vol.17. –Р.1273–1280.172.Tamas Ferenci. The interrelationship of HbA1c and real-time continuousglucose monitoring in children with type 1 diabetes / Tamas Ferenci, Anna Korner,Levente Kovacs //diabetes research and clinical practice.
– 2015. - Vol.108. – Р.38 –44.173.The association between cardiovascular autonomic neuropathy and mortalityin individuals with diabetes: a meta-analysis / R. E. Maser, B. D. Mitchell, A. I.Vinik, R. Freeman //Diabetes Care. - 2003. - Vol.6. –Р.1895–1901.174.The effects of glucose fluctuation on the severity of coronary artery disease intype 2 diabetes mellitus / Х. Zhang, Х. Xu , Х. Jiao et al. // Journal of DiabetesResearch.–2013.-Vol.2013.–Р.1–6.DOI:http://dx.doi.org/10.1155/2013/576916175.The effect of diet on life duration / D. Staffieri, J.
A. Hicklin, L. M. McEwen,J. E. Morgan //S. Afr. Med. J. – 1952. – Vol. 26. – P. 949–950.176.The effect of intensive treatment of diabetes on the development andprogression of long-term complications in insulin-dependent diabetes mellitus/TheDiabetes Control and Complications Trial Research Group //N. Engl. J. Med. - 1993.- Vol.329, №14. – Р.977-986.177.The effect of cardiovascular risk factors on the longitudinal evolution of thecarotid intima medial thickness in children with type 1 diabetes mellitus /RobertDalla Pozza, Andreas Beyerlein , Claude Thilmany et al.// CardiovascularDiabetology.–2011.-Vol.10,53.http://www.cardiab.com/content/10/1/53 (18.10.2014).–Режимдоступа131178.The effect of growth hormone on the development of diabetic kidney diseasein rats /D.
Landau, Е. Israel, I. Rivkis et al.// Nephrol. Dial. Transplant. - 2003. Vol.18 – Р. 694–702.179.The impact of a decade of changing treatment on rates of severe hypoglycemiain a population-based cohort of children with type 1 diabetes / М. К. Bulsara,C. D. Holman, E. A. Davis et al. // Diabetes Care. - 2004. - Vol.27. – Р. 2293–2298.180.The importance of hypoglycemia in diabetic patients / Gita Shafiee,Mohammadreza Mohajeri-Tehrani, Mohammad Pajouhi and Bagher Larijani. //Journal of Diabetes & Metabolic Disorders. – 2012.
- Vol.11,17. - Режим доступа http://www.jdmdonline.com/content/11/17 (5.02.2016)181.The changing natural history of nephropathy in type I diabetes /A. S.Krolewski, J. H. Warram, A. R. Christliebet al. // Am. J. Med. – 1985. - Vol. 78. – Р.785–794.182.The ‗‗glucose pentagon‘‘: assessing glycemic control of patients with diabetesmellitus by a model integrating different parameters from glucose profiles / A.Thomas, M. Scho¨nauer, F.
Achermann et al. // Diabetes. Technol. Ther. - 2009. Vol.11. – Р. 399–409. http://dx.doi.org/10.1089/dia.2008.0119.183.The sympathetic nervous system in diabetic neuropathy: a clinical andpathlogical study /P. A. Low, J. C. Walsh, C. Y. Huang, J. G. McLeod //Brain. –1975. – Vol.98. – P. 341–356.184.The value of cardiovascular autonomic function tests: 10 years' experience indiabetes/D.
J. Ewing, C. N. Martin, R. Y. Young et al. //Diabetes Care. - 1985. Vol.8. –Р.491-498.185.The use and efficacy of continuous glucose monitoring in type 1 diabetestreated with insulin pump therapy: a randomised controlled trial/ T. Battelino, I.Conget, B. Olsenet al., the SWITCH Study Group //Diabetologia. - 2012. - Vol.55. –Р. 3155–3162. DOI 10.1007/s00125-012-2708-9.186.Three-year comparison of subcutaneous insulin pump treatment with multi-daily injections on HbA1c, its variability and hospital burden of children with type 1132diabetes / W. Fendler, A.
I. Baranowska, B. Mianowska et al. //Acta.Diabetol. –2012. - Vol.49. –Р.363–370.187.Type 1 diabetes mellitus: evidence from the literature for appropriatemanagement in children‘s perspective / L. C. Nascimento, M. J. Amaral,V.C. Sparapani et al. //Revistada Escolade Enfermagemda USP. – 2011. -Vol.45, 3.
–Р.760-765. www.ee.usp.br/reeusp/.188.Vinik, A. I. Diabetic Cardiovascular Autonomic Neuropathy/ Aaron I. Vinikand Dan Ziegler // Circulation. – 2007. - Vol.115. – Р.387-397 DOI:10.1161/CIRCULATIONAHA.106.634949189.Vinik, A.I. Recognizing and treating diabetic autonomic neuropathy /A. I. Vinik, T.
Erbas // Cleveland Clinic Journal of medicine. - 2001. - Vol.68, 11. P. 928-944.190.Zenari, L. What are the preferred strategies for control of glycemic variabilityin patients with type 2 diabetes mellitus/ L. Zenari, A. Marangoni // Diabetes Obes.Metab. – 2013. - Vol.15,s2. – Р.17–25. doi: 10.1111/dom.12143..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
